Pharmaceutical manufacturers won a significant federal appeals court decision on 30 January in the ongoing legal dispute with the US Department of Health and Human Services regarding whether they can restrict 340B drug discounts to contract pharmacies.
The US Court of Appeals for the Third Circuit
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?